Professional Summary
Professional Overview
Simon Harford is an accomplished Chief Financial Officer with extensive experience in the pharmaceutical and healthcare industries. He specializes in financial management, strategic planning, and driving operational excellence to support business growth and profitability.
Current Role
As the Chief Financial Officer at Amicus Therapeutics, Simon is responsible for overseeing the company's financial strategy, reporting, and control functions. He plays a crucial role in ensuring the organization's financial stability and supporting its mission to develop and commercialize transformative therapies for rare and orphan diseases.
Career Progression
Simon's career spans over two decades, with a demonstrated track record of success in senior financial leadership roles. Prior to joining Amicus Therapeutics, he served as the Chief Financial Officer at Albireo Pharma, Inc., where he played a pivotal role in the company's financial strategy and growth initiatives. Additionally, he has held prestigious positions such as SVP & Chief Financial Officer at PAREXEL, SVP Finance at GlaxoSmithKline, and various leadership roles at Eli Lilly and Company.
Academic Background
Simon holds a Bachelor's degree in Economics from the University of Cambridge, where he graduated with distinction. He has also completed executive education programs at leading institutions, further enhancing his expertise in strategic financial management and corporate governance.
Areas of Expertise
- Financial management and reporting
- Strategic planning and business transformation
- Mergers, acquisitions, and integration
- Investor relations and capital markets
- Regulatory compliance and risk management
- Building high-performing finance teams
Professional Impact
Throughout his career, Simon has demonstrated a strong track record of driving financial performance, optimizing operational efficiency, and supporting the growth of pharmaceutical and healthcare organizations. He has played a key role in shaping financial strategies, securing funding, and navigating complex regulatory landscapes to enable the successful development and commercialization of innovative therapies.
Conclusion
With his deep industry expertise, strategic mindset, and proven leadership skills, Simon Harford is poised to continue making a substantial impact as the Chief Financial Officer at Amicus Therapeutics. He is committed to leveraging his financial acumen and cross-functional experience to support the company's mission and drive long-term value for its stakeholders.
